Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,381Revenue (TTM) $M533Net Margin (%)-10.6Altman Z-Score37.2
Enterprise Value $M6,259EPS (TTM) $-0.7Operating Margin %-10.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-10.6Higher ROA y-yY
Price/Book27.610-y EBITDA Growth Rate %-17.7Quick Ratio2.5Cash flow > EarningsY
Price/Sales13.25-y EBITDA Growth Rate %-15.7Current Ratio3.0Lower Leverage y-yN
Price/Free Cash Flow1,710y-y EBITDA Growth Rate %--ROA % (ttm)-18.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-24.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M84.5ROIC % (ttm)-47.6Gross Margin Increase y-yN

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DXCMJohn Paulson 2016-09-30 Reduce-0.06%$77.55 - $95.8
($89.02)
$ 85.49-4%Reduce -64.78%43,500
DXCMRon Baron 2016-09-30 Reduce-0.02%$77.55 - $95.8
($89.02)
$ 85.49-4%Reduce -5.57%851,477
DXCMGeorge Soros 2016-09-30 Buy 0.01%$77.55 - $95.8
($89.02)
$ 85.49-4%New holding2,576
DXCMMario Gabelli 2016-09-30 Reduce$77.55 - $95.8
($89.02)
$ 85.49-4%Reduce -0.72%41,600
DXCMJohn Paulson 2016-06-30 Add0.07%$60.63 - $79.33
($68.1)
$ 85.4926%Add 199.03%123,500
DXCMRon Baron 2016-06-30 Reduce-0.07%$60.63 - $79.33
($68.1)
$ 85.4926%Reduce -17.46%901,677
DXCMMario Gabelli 2016-06-30 Reduce$60.63 - $79.33
($68.1)
$ 85.4926%Reduce -3.46%41,900
DXCMJohn Paulson 2016-03-31 Buy 0.02%$53.38 - $81.9
($66.94)
$ 85.4928%New holding41,300
DXCMGeorge Soros 2016-03-31 Sold Out -0.01%$53.38 - $81.9
($66.94)
$ 85.4928%Sold Out0
DXCMMario Gabelli 2016-03-31 Reduce$53.38 - $81.9
($66.94)
$ 85.4928%Reduce -2.25%43,400
DXCMRon Baron 2016-03-31 Add$53.38 - $81.9
($66.94)
$ 85.4928%Add 0.18%1,092,441
DXCMRon Baron 2015-12-31 Reduce-0.09%$70.65 - $88.83
($83.22)
$ 85.493%Reduce -18.06%1,090,473
DXCMGeorge Soros 2015-12-31 Buy 0.01%$70.65 - $88.83
($83.22)
$ 85.493%New holding5,700
DXCMMario Gabelli 2015-12-31 Reduce$70.65 - $88.83
($83.22)
$ 85.493%Reduce -2.20%44,400
DXCMMario Gabelli 2015-09-30 Reduce$79.36 - $101.91
($89.24)
$ 85.49-4%Reduce -10.63%45,400
DXCMRon Baron 2015-09-30 Reduce$79.36 - $101.91
($89.24)
$ 85.49-4%Reduce -0.51%1,330,742
DXCMRon Baron 2015-06-30 Reduce$61.49 - $79.98
($70.13)
$ 85.4922%Reduce -0.06%1,337,607
DXCMJoel Greenblatt 2015-03-31 Sold Out -0.0044%$54.21 - $64.42
($60.43)
$ 85.4941%Sold Out0
DXCMRon Baron 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 85.4941%Reduce -0.17%1,338,407
DXCMMario Gabelli 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 85.4941%Reduce -1.55%50,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DXCM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Balo Andrew KEVP, Clinical and Regulatory 2017-01-10Sell3,200$62.8636.75view
LISTER JOHNGeneral Manager, EMEA 2017-01-09Sell3,000$63.0236.4view
VALDES JORGE ACTO 2017-01-09Sell10,900$63.0236.4view
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2016-12-23Sell3,182$62.1738.27view
ROPER JESSSVP, CFO 2016-12-14Sell2,442$64.1434.02view
VALDES JORGE ACTO 2016-12-09Sell10,000$64.8132.63view
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2016-11-23Sell3,182$70.1922.47view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2016-11-23Sell10,300$70.3222.24view
LISTER JOHNGeneral Manager, EMEA 2016-11-09Sell3,417$62.537.54view
ROPER JESSSVP, CFO 2016-10-24Sell2,471$80.756.45view

Quarterly/Annual Reports about DXCM:

News about DXCM:

Articles On GuruFocus.com
Weekly CFO Sells Highlight Jun 28 2016 
Baron Funds Comments on DexCom Inc. Jan 14 2016 
Investing for Lower Risk Long-Term Growth in a Volatile Asset Class - Baron Funds Winter Newsletter Jan 14 2016 
Top Weekly Insider Sells Highlights Sep 15 2015 
Weekly CFO Sells Highlight: Gilead Sciences, DexCom, and Palo Alto Networks Sep 13 2015 
Panic-Proofing the Small Investor Aug 26 2015 
Baron Funds Comments on DexCom Inc. Aug 19 2015 
Weekly CFO Sells Highlight: Cigna Corp, Comcast Corp, and DexCom Inc. Jul 20 2015 
Weekly Insider Sells Highlight: GILD, AXTA, GME, DXCM Jul 14 2015 
Weekly CFO Sells Highlight: Axalta Coating Systems Ltd, Palo Alto Networks Inc, DexCom Inc. Jul 13 2015 

More From Other Websites
DexCom Jumps 25% As It Becomes Only Continuous Glucose Monitoring With Medicare Coverage Jan 13 2017
4 Companies That Beat Friday the 13th Jan 13 2017
Centers for Medicare & Medicaid Services (CMS) Classify Therapeutic Continuous Glucose Monitors... Jan 12 2017
DexCom, Inc. – Value Analysis (NASDAQ:DXCM) : January 12, 2017 Jan 12 2017
DexCom: Look, but Don't Touch Jan 11 2017
DexCom Looking Forward to Strong Revenues in Q4 and 2016 Jan 11 2017
DexCom, Inc. breached its 50 day moving average in a Bullish Manner : DXCM-US : January 11, 2017 Jan 11 2017
The launch of Dexcom Canada will reshape how Canadians living with diabetes access and use... Jan 11 2017
DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jan 10 2017
DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and... Jan 10 2017
Dexcom downgraded by Morgan Stanley Jan 03 2017
DexCom (DXCM) Gains FDA Approval for G5 Mobile CGM System Dec 21 2016
FDA Approval of Dexcom's Non-Adjunctive Indication Triggers a New Era in Diabetes Management Dec 20 2016
FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes Management Dec 20 2016
DexCom Announces Upcoming Conference Presentation Dec 19 2016
DexCom Announces Upcoming Conference Presentation Dec 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)